His scientific interests lie mostly in Autoantibody, Immunology, Bullous pemphigoid, Pemphigus and Dermatology. His Autoantibody study focuses on Epidermolysis bullosa acquisita in particular. In his research, Cell adhesion and Cell biology is intimately related to Keratinocyte, which falls under the overarching field of Immunology.
When carried out as part of a general Bullous pemphigoid research project, his work on Pemphigoid is frequently linked to work in Doxycycline, therefore connecting diverse disciplines of study. Enno Schmidt has included themes like Pemphigus vulgaris, Desmoglein, Rheumatoid arthritis and Rituximab in his Pemphigus study. The Dermatology study combines topics in areas such as Differential diagnosis, Adjuvant, Severity of illness, Pemphigoid Gestationis and Immunoadsorption.
His primary areas of investigation include Immunology, Autoantibody, Bullous pemphigoid, Dermatology and Pemphigoid. His work carried out in the field of Autoantibody brings together such families of science as Pemphigus, Direct fluorescent antibody and Disease, Pathology. He combines subjects such as Desmoglein, Rituximab and Pemphigus vulgaris with his study of Pemphigus.
His work is dedicated to discovering how Bullous pemphigoid, Internal medicine are connected with Gastroenterology and other disciplines. His studies deal with areas such as Adjuvant, Immunoadsorption and MEDLINE as well as Dermatology. His Pemphigoid research is multidisciplinary, incorporating elements of Serology and Recombinant DNA.
Enno Schmidt spends much of his time researching Bullous pemphigoid, Autoantibody, Pemphigoid, Dermatology and Pemphigus. Immunology and Antibody are the two main areas of interest in his Bullous pemphigoid studies. His work in Autoantibody covers topics such as Direct fluorescent antibody which are related to areas like Biopsy.
The study incorporates disciplines such as Cell biology, Epidermolysis bullosa acquisita, Serology and Pathology in addition to Pemphigoid. His work deals with themes such as Guideline and MEDLINE, which intersect with Dermatology. Enno Schmidt has included themes like Desmoglein, Rituximab and Pemphigus vulgaris in his Pemphigus study.
Enno Schmidt mostly deals with Pemphigoid, Bullous pemphigoid, Dermatology, Pemphigus and Autoantibody. His Pemphigoid research includes elements of Inflammation, Autoimmunity, Immune system and Pathology. His Bullous pemphigoid study deals with the bigger picture of Immunology.
His work investigates the relationship between Dermatology and topics such as MEDLINE that intersect with problems in Virology and Desmosome. Enno Schmidt has researched Pemphigus in several fields, including Pemphigus vulgaris, Guideline, Therapeutic trial, Desmoglein and Gynecology. His Autoantibody study incorporates themes from Internal medicine, Skin pathology, Antigen and Complement fixation test.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.
Enno Schmidt;Karin Obe;Eva-Bettina Bröcker;Detlef Zillikens.
Archives of Dermatology (2000)
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.
N. Hunzelmann;E. Genth;T. Krieg;W. Lehmacher.
Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany
Franziska Bertram;Eva‐B. Bröcker;Detlef Zillikens;Detlef Zillikens;Enno Schmidt;Enno Schmidt.
Journal Der Deutschen Dermatologischen Gesellschaft (2009)
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Dedee F. Murrell;Benjamin S. Daniel;Pascal Joly;Luca Borradori.
Journal of The American Academy of Dermatology (2012)
Mechanisms of Autoantibody-Induced Pathology.
Ralf J. Ludwig;Karen Vanhoorelbeke;Frank Leypoldt;Ziya Kaya.
Frontiers in Immunology (2017)
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
Hans-Peter Tony;Gerd Burmester;Hendrik Schulze-Koops;Mathias Grunke.
Arthritis Research & Therapy (2011)
Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Cassian Sitaru;Enno Schmidt;Steffen Petermann;Luminita S. Munteanu.
Journal of Investigative Dermatology (2002)
Modern diagnosis of autoimmune blistering skin diseases.
Enno Schmidt;Detlef Zillikens.
Autoimmunity Reviews (2010)
IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: Serum levels of these immunoglobulins reflect disease activity
Rebekka Döpp;Enno Schmidt;Iakov Chimanovitch;Martin Leverkus.
Journal of The American Academy of Dermatology (2000)
Rituximab in autoimmune bullous diseases: mixed responses and adverse effects.
E. Schmidt;C.S. Seitz;S. Benoit;E.B. Bröcker.
British Journal of Dermatology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: